We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
-7.42%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$59.2M
AUM Growth
-$17.5M
Cap. Flow
-$3.37M
Cap. Flow %
-5.68%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$1.7M
2
IOTS
Adesto Technologies Corp
IOTS
+$1.67M

Sector Composition

Rank Sector Weight
1 Healthcare 64.55%
2 Technology 35.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOTS
1
DELISTED
Adesto Technologies Corp
IOTS
$21M 35.45%
1,876,511
-175,000
-9% -$1.67M
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$18.2M 30.67%
306,382
-25,000
-8% -$1.7M
RUBY
3
DELISTED
Rubius Therapeutics, Inc
RUBY
$11.7M 19.67%
2,618,351
– –
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
$4.37M 7.37%
1,196,776
– –
KURA icon
5
Kura Oncology
KURA
$921M
$4.04M 6.83%
406,307
– –

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q1 2020 Portfolio in Review

As of Q1 2020, Arch Venture Management held 5 positions worth $59.2M, down 23% from $76.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Arch Venture Management withdrew a net $3.37M in Q1 2020, reducing 2 holdings. Its largest reduction was Syros Pharmaceuticals, Inc. Common Stock, cutting an estimated $1.7M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, down from 77% a quarter earlier, followed by Technology.

  • Arch Venture Management's biggest Q1 2020 reduction was Syros Pharmaceuticals, Inc. Common Stock, cutting an estimated $1.7M.
  • Arch Venture Management's ten largest holdings make up 100% of its $59.2M portfolio in Q1 2020.
  • Arch Venture Management opened 0 new positions and closed 0 in Q1 2020.
  • Arch Venture Management's portfolio value fell 23% quarter-over-quarter to $59.2M.

Based on Arch Venture Management's 13F filing for Q1 2020, filed 6 May 2020.